Articles by Dirk Schürmann

A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals

Schürmann, Dirk; Sobotha, Christian; Gilmartin, Jocelyn; More

AIDS. 30(1):57-63, January 2nd, 2016.

Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults

Schürmann, Dirk; Fätkenheuer, Gerd; Reynes, Jacques; More

AIDS. 21(10):1293-1299, June 2007.

Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection

Schmutz, Guenther; Nelson, Mark; Lutz, Thomas; More

AIDS. 20(15):1951-1954, October 3rd, 2006.